Casebia combines CRISPR/Cas9 expertise and technology from CRISPR Therapeutics with access to deep disease-state knowledge and protein engineering capabilities from Bayer.
610 Main Street, North Building, 5th Floor, Cambridge, Massachusetts 02139
The Synthetic Genome
Founded in 2019, Oxfordshire, United Kingdom
© BioTechScope Ltd. All rights reserved